CJC-1295 and ipamorelin are commonly combined in research involving growth-hormone signaling. CJC-1295 is a growth-hormone-releasing hormone analog, while ipamorelin is a growth-hormone secretagogue. Research interest includes recovery, body composition, sleep, and growth-hormone regulation.